Halvard Bönig

9.0k total citations
210 papers, 4.7k citations indexed

About

Halvard Bönig is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Halvard Bönig has authored 210 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Hematology, 94 papers in Oncology and 81 papers in Immunology. Recurrent topics in Halvard Bönig's work include Hematopoietic Stem Cell Transplantation (76 papers), CAR-T cell therapy research (51 papers) and Immune Cell Function and Interaction (43 papers). Halvard Bönig is often cited by papers focused on Hematopoietic Stem Cell Transplantation (76 papers), CAR-T cell therapy research (51 papers) and Immune Cell Function and Interaction (43 papers). Halvard Bönig collaborates with scholars based in Germany, United States and United Kingdom. Halvard Bönig's co-authors include Thalia Papayannopoulou, Erhard Seifried, Gregory V. Priestley, Darja Karpova, Heike Bialleck, Dieter Körholz, Erhard Seifried, T Papayannopoulou, Susanne Bräuninger and Beate Luxembourg and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Halvard Bönig

203 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Halvard Bönig Germany 39 1.7k 1.6k 1.4k 1.4k 686 210 4.7k
David B. Miklos United States 37 2.2k 1.3× 2.1k 1.4× 1.5k 1.0× 2.6k 1.8× 810 1.2× 224 6.5k
Frederic I. Preffer United States 43 2.0k 1.2× 1.6k 1.0× 2.0k 1.4× 2.3k 1.6× 553 0.8× 112 7.0k
Andreas Beilhack Germany 32 1.3k 0.7× 1.4k 0.9× 1.2k 0.8× 2.6k 1.8× 315 0.5× 120 4.8k
Riccardo Saccardi Italy 46 1.5k 0.8× 1.8k 1.1× 1.1k 0.8× 1.2k 0.8× 340 0.5× 181 6.1k
Frances T. Hakim United States 31 2.1k 1.2× 1.8k 1.2× 1.2k 0.8× 2.9k 2.0× 577 0.8× 82 5.7k
Ronjon Chakraverty United Kingdom 35 1.5k 0.9× 1.7k 1.1× 999 0.7× 2.2k 1.5× 544 0.8× 87 5.2k
Robert Sackstein United States 48 1.8k 1.0× 2.2k 1.4× 2.4k 1.7× 2.7k 1.9× 645 0.9× 150 7.5k
Lawrence G. Lum United States 39 1.9k 1.1× 971 0.6× 1.0k 0.7× 2.2k 1.5× 340 0.5× 212 4.7k
Dagmar Dilloo Germany 29 1.4k 0.8× 1.1k 0.7× 1.2k 0.8× 1.4k 1.0× 778 1.1× 92 4.7k
Hans‐Georg Kopp Germany 37 3.2k 1.8× 1.2k 0.8× 1.6k 1.1× 1.3k 0.9× 241 0.4× 172 6.5k

Countries citing papers authored by Halvard Bönig

Since Specialization
Citations

This map shows the geographic impact of Halvard Bönig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halvard Bönig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halvard Bönig more than expected).

Fields of papers citing papers by Halvard Bönig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Halvard Bönig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halvard Bönig. The network helps show where Halvard Bönig may publish in the future.

Co-authorship network of co-authors of Halvard Bönig

This figure shows the co-authorship network connecting the top 25 collaborators of Halvard Bönig. A scholar is included among the top collaborators of Halvard Bönig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Halvard Bönig. Halvard Bönig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bexte, Tobias, Stephanie Hehlgans, Florian Rothweiler, et al.. (2025). Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapy. Journal for ImmunoTherapy of Cancer. 13(7). e011330–e011330.
2.
Macas, Jadranka, Eliza Wiercinska, Patrick N. Harter, et al.. (2023). Wnt/β-Catenin-Signaling Modulates Megakaryopoiesis at the Megakaryocyte-Erythrocyte Progenitor Stage in the Hematopoietic System. Cells. 12(23). 2765–2765. 4 indexed citations
3.
Bremm, Melanie, Halvard Bönig, Kathrin Vogelsang, et al.. (2023). Validation of an ICH Q2 Compliant Flow Cytometry-Based Assay for the Assessment of the Inhibitory Potential of Mesenchymal Stromal Cells on T Cell Proliferation. Cells. 12(6). 850–850. 4 indexed citations
4.
Jarisch, Andrea, Emilia Salzmann‐Manrique, Jan Soerensen, et al.. (2023). Donor‐type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors. British Journal of Haematology. 201(6). 1159–1168.
5.
Worel, Nina, et al.. (2023). A guide to the collection of T-cells by apheresis for ATMP manufacturing—recommendations of the GoCART coalition apheresis working group. Bone Marrow Transplantation. 58(7). 742–748. 8 indexed citations
6.
Hemmersbach, Ruth, et al.. (2023). Simulating Space Conditions Evokes Different DNA Damage Responses in Immature and Mature Cells of the Human Hematopoietic System. International Journal of Molecular Sciences. 24(18). 13761–13761. 4 indexed citations
7.
Kumar, Rahul, Raquel Pereira, Valentina R. Minciacchi, et al.. (2022). The differential role of the lipid raft-associated protein flotillin 2 for progression of myeloid leukemia. Blood Advances. 6(12). 3611–3624. 11 indexed citations
8.
Baldauf, Hanna‐Mari, Stefan Stein, Gerrit Kann, et al.. (2022). HIV-1 Infection of Long-Lived Hematopoietic Precursors In Vitro and In Vivo. Cells. 11(19). 2968–2968. 11 indexed citations
9.
Frenz, Silke, María‐Belén Vídriales, Marcos González, et al.. (2021). Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia. Blood. 138(19). 1830–1842. 74 indexed citations
10.
Wagner, Juliane, Hermann Kreyenberg, Winfried S. Wels, et al.. (2020). ERBB2-CAR-Engineered Cytokine-Induced Killer Cells Exhibit Both CAR-Mediated and Innate Immunity Against High-Risk Rhabdomyosarcoma. Frontiers in Immunology. 11. 581468–581468. 29 indexed citations
11.
Spohn, Gabriele, et al.. (2020). Adaptive Immunity and Pathogenesis of Diabetes: Insights Provided by the α4–Integrin Deficient NOD Mouse. Cells. 9(12). 2597–2597. 3 indexed citations
12.
Ghanaati, Shahram, Sarah Al‐Maawi, Carlos Herrera-Vizcaíno, et al.. (2018). A Proof of the Low Speed Centrifugation Concept in Rodents: New Perspectives for In Vivo Research. Tissue Engineering Part C Methods. 24(11). 659–670. 15 indexed citations
13.
Bremm, Melanie, Sabine Huenecke, Andrea Quaiser, et al.. (2016). In-vitro influence of mycophenolate mofetil (MMF) and Ciclosporin A (CsA) on cytokine induced killer (CIK) cell immunotherapy. Journal of Translational Medicine. 14(1). 264–264. 8 indexed citations
14.
Straetemans, Trudy, Sabine Heijhuurs, Samantha Hol, et al.. (2015). Untouched GMP-Ready Purified Engineered Immune Cells to Treat Cancer. Clinical Cancer Research. 21(17). 3957–3968. 22 indexed citations
15.
Seebach, Caroline, Dirk Henrich, Alexander Schaible, et al.. (2015). Cell-Based Therapy by Implanted Human Bone Marrow-Derived Mononuclear Cells Improved Bone Healing of Large Bone Defects in Rats. Tissue Engineering Part A. 21(9-10). 1565–1578. 44 indexed citations
16.
Kolodziej, Stephan, Olga N. Kuvardina, Thomas Oellerich, et al.. (2014). PADI4 acts as a coactivator of Tal1 by counteracting repressive histone arginine methylation. Nature Communications. 5(1). 3995–3995. 56 indexed citations
17.
Kaufmann, Kerstin B., Tobias Abel, Christian Brendel, et al.. (2014). CD105 Is a Surface Marker for Receptor-Targeted Gene Transfer into Human Long-Term Repopulating Hematopoietic Stem Cells. Stem Cells and Development. 24(6). 714–723. 15 indexed citations
18.
Spohn, Gabriele, Darja Karpova, Eliza Wiercinska, et al.. (2014). Functional Consequences of Perturbed CXCL12 Signal Processing: Analyses of Immature Hematopoiesis in GRK6-Deficient Mice. Stem Cells and Development. 24(6). 737–746. 10 indexed citations
19.
Bönig, Halvard, Gregory V. Priestley, Martin E. Wohlfahrt, Hans‐Peter Kiem, & Thalia Papayannopoulou. (2008). Blockade of α6-Integrin Reveals Diversity in Homing Patterns Among Human, Baboon, and Murine Cells. Stem Cells and Development. 18(6). 839–844. 9 indexed citations
20.
Schneider, Dominik T., W. Nürnberger, H. Stannigel, Halvard Bönig, & U. Göbel. (1999). Adjuvant treatment of severe acute pancreatitis with C1 esterase inhibitor concentrate after haematopoietic stem cell transplantation. Gut. 45(5). 733–736. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026